These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10690840)

  • 41. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new human eye model for ophthalmic brachytherapy dosimetry.
    Yoriyaz H; Sanchez A; dos Santos A
    Radiat Prot Dosimetry; 2005; 115(1-4):316-9. PubMed ID: 16381737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absorbed dose distributions from ophthalmic
    Hermida-López M; Brualla L
    Med Phys; 2018 Apr; 45(4):1699-1707. PubMed ID: 29399810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.
    Schiefer H; von Toggenburg F; Seelentag W; Plasswilm L; Ries G; Lenggenhager C; Schmid HP; Leippold T; Prikler L; Krusche B; Roth J; Engeler D
    Strahlenther Onkol; 2009 Oct; 185(10):689-95. PubMed ID: 19806335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of 125I ophthalmic plaque brachytherapy.
    Astrahan MA; Luxton G; Jozsef G; Liggett PE; Petrovich Z
    Med Phys; 1990; 17(6):1053-7. PubMed ID: 2280735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 125I eye plaque dose distribution including penumbra characteristics.
    de la Zerda A; Chiu-Tsao ST; Lin J; Boulay LL; Kanna I; Kim JH; Tsao HS
    Med Phys; 1996 Mar; 23(3):407-18. PubMed ID: 8815384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dosimetry of 125I seed eye plaques.
    Weaver KA
    Med Phys; 1986; 13(1):78-83. PubMed ID: 3814235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plaque radiotherapy for the management of uveal metastasis.
    Shields CL; Shields JA; De Potter P; Quaranta M; Freire J; Brady LW; Barrett J
    Arch Ophthalmol; 1997 Feb; 115(2):203-9. PubMed ID: 9046255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of treatment results in 36 children with retinoblastoma treated by scleral plaque irradiation.
    Amendola BE; Markoe AM; Augsburger JJ; Karlsson UL; Giblin M; Shields JA; Brady LW; Woodleigh R
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):63-70. PubMed ID: 2745209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimates of relative beta radiation doses on central and lateral axes of ruthenium/rhodium COB-type plaque used in eye brachytherapy.
    De Paiva E
    Appl Radiat Isot; 2020 Feb; 156():108991. PubMed ID: 32056686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.
    Hashemi S; Aghamiri MR; Kahani M; Jaberi R
    Int J Nanomedicine; 2019; 14():4157-4165. PubMed ID: 31239674
    [No Abstract]   [Full Text] [Related]  

  • 53. Solid phantom material for the dosimetry of iodine-125 seed ophthalmic plaques.
    Hermann KP; Alberti W; Tabor P; Pothmann B; Divoux S; Harder D
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):897-901. PubMed ID: 8344860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The determination of dose characteristics of ruthenium ophthalmic applicators using radiochromic film.
    Taccini G; Cavagnetto F; Coscia G; Garelli S; Pilot A
    Med Phys; 1997 Dec; 24(12):2034-7. PubMed ID: 9434987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Finger's amniotic membrane buffer technique: protecting the cornea during radiation plaque therapy.
    Finger PT
    Arch Ophthalmol; 2008 Apr; 126(4):531-4. PubMed ID: 18413524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress in the use of iodine therapy for tumours of the eye.
    Sealy R; Buret E; Cleminshaw H; Stannard C; Hering E; Shackleton D; Korrubel J; le Roux PL; Sevel D; van Oldenborgh M; van Selm J
    Br J Radiol; 1980 Nov; 53(635):1052-60. PubMed ID: 7426931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetric characterization of a 131Cs brachytherapy source by thermoluminescence dosimetry in liquid water.
    Tailor R; Ibbott G; Lampe S; Warren WB; Tolani N
    Med Phys; 2008 Dec; 35(12):5861-8. PubMed ID: 19175142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment.
    Shields CL; Shields JA; De Potter P; Minelli S; Hernandez C; Brady LW; Cater JR
    Ophthalmology; 1993 Feb; 100(2):216-24. PubMed ID: 8437830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of gold shielding on the dosimetry of an 125I seed at close range.
    Wu A; Sternick ES; Muise DJ
    Med Phys; 1988; 15(4):627-8. PubMed ID: 3211059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
    Gagne NL; Rivard MJ
    Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.